Polymorphisms in base excision repair genes and thyroid cancer risk

Santos,Luís  S.; Branco,Sandra  C.; Silva,Susana  N.; Azevedo,Ana   Paula; Gil,Octávia  M.; Manita,Isabel; Ferreira,Teresa  C.; Limbert,Edward; Rueff,José; Gaspar,Jorge  F.

doi:10.3892/or.2012.1975

Polymorphisms in base excision repair genes and thyroid cancer risk

Authors:
- Luís S. Santos
- Sandra C. Branco
- Susana N. Silva
- Ana Paula Azevedo
- Octávia M. Gil
- Isabel Manita
- Teresa C. Ferreira
- Edward Limbert
- José Rueff
- Jorge F. Gaspar
View Affiliations

Affiliations: Department of Genetics, Faculty of Medical Sciences, Universidade Nova de Lisboa, Lisbon, Portugal, Department of Biochemistry, Faculty of Medical Sciences, Universidade Nova de Lisboa, Lisbon, Portugal, Unit of Endocrinology, Hospital Garcia de Orta, Almada, Portugal, Department of Nuclear Medicine, Portuguese Oncology Institute of Lisbon, Lisbon, Portugal
Published online on: August 22, 2012 https://doi.org/10.3892/or.2012.1975
Pages: 1859-1868

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Thyroid cancer (TC) is the most frequent endocrine malignancy, accounting however for only 1-2% of all human cancers, and the best-established risk factor for TC is radiation exposure, particularly during childhood. Since the BER pathway seems to play an important role in the repair of DNA damage induced by IR and other genotoxicants, we carried out a hospital-based case-control study in order to evaluate the potential modifying role of 6 BER polymorphisms on the individual susceptibility to non-familial TC in 109 TC patients receiving iodine-131, and 217 controls matched for age (±2 years), gender and ethnicity. Our results do not reveal a significant involvement of XRCC1 Arg194Trp and Arg399Gln, OGG1 Ser326Cys, APEX1 Asp148Glu, MUTYH Gln335His and PARP1 Val762Ala polymorphisms on the individual susceptibility towards TC, mostly in aggreement with the limited available evidence. By histological stratification analyis, we observed that the association between the presence of heterozygozity in the MUTYH Gln335His polymorphism and TC risk almost reached significance for the papillary subtype of TC. This was the first time that the putative association between this polymorphism and TC susceptibility was evaluated. However, since the sample size was modest, the possibility of a type I error should not be excluded and this result should, therefore, be interpreted with caution. More in depth studies involving larger populations should be pursued in order to further clarify the potential usefulness of the MUTYH Gln335His genotype as a predictive biomarker of susceptibility to TC and the role of the remaining BER polymorphisms on TC susceptibility.

View Figures

View References

1	De Lellis RA and Williams ED: Tumours of the thyroid and parathyroid. Pathology and Genetics of Tumours of Endocrine Organs. De Lellis RA, Lloyd RV, Heitz PU and Eng C: IARC Press; Lyon: pp. 51–56. 2004
2	Dal Maso L, Bosetti C, La Vecchia C and Franceschi S: Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control. 20:75–86. 2009.PubMed/NCBI
3	Landa I and Robledo M: Association studies in thyroid cancer susceptibility: are we on the right track? J Mol Endocrinol. 47:R43–R58. 2011. View Article : Google Scholar
4	Sarasin A, Bounacer A, Lepage F, Schlumberger M and Suarez H: Mechanisms of mutagenesis in mammalian cells. Application to human thyroid tumours. C R Acad Sci III. 322:143–149. 1999. View Article : Google Scholar : PubMed/NCBI
5	Adjadj E, Schlumberger M and de Vathaire F: Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol. 10:181–190. 2009. View Article : Google Scholar : PubMed/NCBI
6	Gudmundsson J, Sulem P, Gudbjartsson DF, et al: Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet. 41:460–464. 2009. View Article : Google Scholar
7	Hoeijmakers JHJ: Genome maintenance mechanisms for preventing cancer. Nature. 411:366–374. 2001. View Article : Google Scholar : PubMed/NCBI
8	Sigurdson AJ, Hauptmann M, Alexander BH, Doody MM, Thomas CB, Struewing JP and Jones IM: DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. Mutat Res. 586:173–188. 2005. View Article : Google Scholar : PubMed/NCBI
9	Gatzidou E, Michailidi C, Tseleni-Balafouta S and Theocharis S: An epitome of DNA repair related genes and mechanisms in thyroid carcinoma. Cancer Lett. 290:139–147. 2010. View Article : Google Scholar : PubMed/NCBI
10	Wilson DM III, Kim D, Berquist BR and Sigurdson AJ: Variation in base excision repair capacity. Mutat Res. 711:100–112. 2011. View Article : Google Scholar : PubMed/NCBI
11	Hung RJ, Hall J, Brennan P and Boffetta P: Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol. 162:925–942. 2005. View Article : Google Scholar : PubMed/NCBI
12	Silva SN, Gil OM, Oliveira VC, et al: Association of polymorphisms in ERCC2 gene with non-familial thyroid cancer risk. Cancer Epidemiol Biomarkers Prev. 14:2407–2412. 2005. View Article : Google Scholar : PubMed/NCBI
13	Gomes BC, Silva SN, Azevedo AP, et al: The role of common variants of non-homologous end-joining repair genes XRCC4, LIG4 and Ku80 in thyroid cancer risk. Oncol Rep. 24:1079–1085. 2010.PubMed/NCBI
14	Bastos HN, Antão MR, Silva SN, et al: Association of polymorphisms in genes of the homologous recombination DNA repair pathway and thyroid cancer risk. Thyroid. 19:1067–1075. 2009. View Article : Google Scholar : PubMed/NCBI
15	Xu L, Doan PC, Wei Q, Liu Y, Li G and Sturgis EM: Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinomaa. Thyroid. 22:35–43. 2012. View Article : Google Scholar : PubMed/NCBI
16	Silva SN, Gomes BC, Rueff J and Gaspar JF: DNA repair perspectives in thyroid and breast cancer: the role of DNA repair polymorphisms. DNA Repair and Human Health. Vengrova S: InTech; pp. 459–484. 2011
17	Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A and Case LD: Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 22:917–922. 2001. View Article : Google Scholar : PubMed/NCBI
18	Vodicka P, Stetina R, Polakova V, et al: Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis. 28:657–664. 2007. View Article : Google Scholar : PubMed/NCBI
19	Silva SN, Moita R, Azevedo AP, et al: Menopausal age and XRCC1 gene polymorphisms: role in breast cancer risk. Cancer Detect Prev. 31:303–309. 2007. View Article : Google Scholar : PubMed/NCBI
20	Lange K, Cantor R, Horvath S, Perola M, Sabatti C, Sinsheimer J and Sobel E: Mendel version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet. 69:A18862001.
21	Kiuru A, Lindholm C, Heinavaara S, et al: XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol. 88:135–142. 2008. View Article : Google Scholar : PubMed/NCBI
22	Zhang Y, Newcomb PA, Egan KM, et al: Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 15:353–358. 2006. View Article : Google Scholar : PubMed/NCBI
23	Conde J, Silva S, Azevedo A, Teixeira V, Pina J, Rueff J and Gaspar J: Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study. BMC Cancer. 9:3442009. View Article : Google Scholar : PubMed/NCBI
24	Ginsberg G, Angle K, Guyton K and Sonawane B: Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment. Mutat Res. 727:1–15. 2011. View Article : Google Scholar : PubMed/NCBI
25	Chiang FY, Wu CW, Hsiao PJ, et al: Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res. 14:5919–5924. 2008. View Article : Google Scholar : PubMed/NCBI
26	García-Quispes WA, Pérez-Machado G, Akdi A, et al: Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer. Mutat Res. 709–710:67–72. 2011.PubMed/NCBI
27	Ryu RA, Tae K, Min HJ, Jeong JH, Cho SH, Lee SH and Ahn YH: XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample. J Korean Med Sci. 26:991–995. 2011. View Article : Google Scholar : PubMed/NCBI
28	Sigurdson AJ, Land CE, Bhatti P, et al: Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res. 171:77–88. 2009. View Article : Google Scholar
29	Ho T, Li G, Lu J, Zhao C, Wei Q and Sturgis EM: Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid. 19:129–135. 2009. View Article : Google Scholar : PubMed/NCBI
30	Akulevich NM, Saenko VA, Rogounovitch TI, et al: Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer. 16:491–503. 2009. View Article : Google Scholar : PubMed/NCBI
31	Wei B, Zhou Y, Xu Z, et al: The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis. PLoS One. 6:e275452011. View Article : Google Scholar : PubMed/NCBI
32	Gu D, Wang M, Zhang Z and Chen J: Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies. Breast Cancer Res Treat. 122:527–531. 2010. View Article : Google Scholar : PubMed/NCBI
33	Yuan W, Xu L, Feng Y, et al: The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 122:835–842. 2010. View Article : Google Scholar : PubMed/NCBI
34	David SS, O'Shea VL and Kundu S: Base-excision repair of oxidative DNA damage. Nature. 447:941–950. 2007. View Article : Google Scholar : PubMed/NCBI
35	Cheadle JP and Sampson JR: MUTYH-associated polyposis - from defect in base excision repair to clinical genetic testing. DNA Repair. 6:274–279. 2007. View Article : Google Scholar : PubMed/NCBI
36	Aretz S, Uhlhaas S, Goergens H, et al: MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 119:807–814. 2006. View Article : Google Scholar
37	Pervaiz M, Eppolito A and Schmidt K: Papillary thyroid cancer in a patient with MUTYH-associated polyposis (MAP). Fam Cancer. 9:595–597. 2010. View Article : Google Scholar : PubMed/NCBI
38	Ali M, Kim H, Cleary S, Cupples C, Gallinger S and Bristow R: Characterization of mutant MUTYH proteins associated with familial colorectal cancer. Gastroenterology. 135:499–507. 2008. View Article : Google Scholar : PubMed/NCBI
39	Picelli S, Zajac P, Zhou XL, et al: Common variants in human CRC genes as low-risk alleles. Eur J Cancer. 46:1041–1048. 2010. View Article : Google Scholar : PubMed/NCBI
40	Tao H, Shinmura K, Suzuki M, et al: Association between genetic polymorphisms of the base excision repair gene MUTYH and increased colorectal cancer risk in a Japanese population. Cancer Sci. 99:355–360. 2008. View Article : Google Scholar : PubMed/NCBI
41	Miyaishi A, Osawa K, Osawa Y, et al: MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. J Exp Clin Cancer Res. 28:102009. View Article : Google Scholar : PubMed/NCBI
42	Qian B, Zhang H, Zhang L, Zhou X, Yu H and Chen K: Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 73:138–146. 2011. View Article : Google Scholar : PubMed/NCBI
43	Huang M, Dinney CP, Lin X, Lin J, Grossman HB and Wu X: High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 16:84–91. 2007. View Article : Google Scholar : PubMed/NCBI
44	Jiang J, Zhang X, Yang H and Wang W: Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. Methods Mol Biol. 471:305–333. 2009. View Article : Google Scholar : PubMed/NCBI
45	Miao X, Zhang X, Zhang L, et al: Adenosine diphosphate ribosyl transferase and X-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer. Gastroenterology. 131:420–427. 2006. View Article : Google Scholar : PubMed/NCBI
46	Zhai X, Liu J, Hu Z, et al: Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Glu and risk of breast cancer in Chinese women: a case control analysis. Oncol Rep. 15:247–252. 2006.PubMed/NCBI